​

CervoMed (CRVO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

CRVO Stock Forecast

CervoMed (CRVO) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $20.00, with a high of $20.00 and a low of $20.00. This represents a 196.74% increase from the last price of $6.74.

- $5 $10 $15 $20 $25 High: $20 Avg: $20 Low: $20 Last Closed Price: $6.74

CRVO Stock Rating

CervoMed stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (85.71%), 1 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 1 6 Strong Sell Sell Hold Buy Strong Buy

CRVO Price Target Upside V Benchmarks

TypeNameUpside
StockCervoMed196.74%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts122
Avg Price Target$20.00$18.00$18.00
Last Closing Price$6.74$6.74$6.74
Upside/Downside196.74%167.06%167.06%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25-61--7
Sep, 25-6---6
Aug, 2516---7
Jul, 2515---6
Jun, 25151--7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 17, 2025Roth Capital$20.00$7.60163.16%196.74%
Aug 12, 2025Boobalan PachaiyappanRoth Capital$16.00$9.4170.03%137.39%
Sep 18, 2024Danill GataulinLoop Capital Markets$16.32$4.79240.71%142.14%
Sep 18, 2024Daniil GataulinChardan Capital$16.32$4.79240.71%142.14%
Apr 08, 2024Sumant KulkarniCanaccord Genuity$19.29$6.08217.27%186.20%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 17, 2025Roth CapitalBuyBuyhold
Sep 08, 2025H.C. WainwrightNeutralNeutralhold
Aug 12, 2025Roth CapitalBuyBuyhold
Dec 17, 2024H.C. WainwrightBuyNeutraldowngrade
Dec 11, 2024Morgan StanleyOverweightUnderweightdowngrade
Sep 18, 2024Chardan CapitalBuyinitialise
Jul 26, 2024Morgan StanleyOverweightinitialise
Apr 08, 2024Canaccord GenuityBuyBuyhold
Aug 16, 2022H.C. WainwrightBuyupgrade

Financial Forecast

EPS Forecast

$-8 $-7 $-6 $-5 $-4 $-3 $-2 $-1 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.82$-2.02----
Avg Forecast$-3.57$-1.85$-1.64$-2.20$-1.26$-1.36
High Forecast$-0.82$-1.58$-1.18$-0.50$-0.29$-0.31
Low Forecast$-7.46$-2.08$-2.12$-4.61$-2.64$-2.85
Surprise %-77.03%9.19%----

Revenue Forecast

$0 $3M $6M $9M $12M $15M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.14M-----
Avg Forecast$4.35M$8.05M$4.81M$7.14M$7.14M$5.20M
High Forecast$8.01M$9.61M$6.89M$13.16M$13.16M$9.57M
Low Forecast$1.77M$7.07M$2.22M$2.91M$2.91M$2.12M
Surprise %64.25%-----

Net Income Forecast

$-20M $-16M $-12M $-8M $-4M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.17M$-16.29M----
Avg Forecast$-11.02M$-4.88M$-4.39M$-6.81M$-3.89M$-3.62M
High Forecast$-2.17M$-4.21M$-3.14M$-1.34M$-767.90K$-828.85K
Low Forecast$-19.86M$-5.54M$-5.64M$-12.28M$-7.02M$-7.58M
Surprise %-80.29%233.98%----

CRVO Forecast FAQ

Is CervoMed stock a buy?

CervoMed stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that CervoMed is a favorable investment for most analysts.

What is CervoMed's price target?

CervoMed's price target, set by 7 Wall Street analysts, averages $20 over the next 12 months. The price target range spans from $20 at the low end to $20 at the high end, suggesting a potential 196.74% change from the previous closing price of $6.74.

How does CervoMed stock forecast compare to its benchmarks?

CervoMed's stock forecast shows a 196.74% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for CervoMed over the past three months?

  • October 2025: 0% Strong Buy, 85.71% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 14.29% Strong Buy, 85.71% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is CervoMed’s EPS forecast?

CervoMed's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.64, marking a -18.81% decrease from the reported $-2.02 in 2024. Estimates for the following years are $-2.2 in 2026, $-1.26 in 2027, and $-1.36 in 2028.

What is CervoMed’s revenue forecast?

CervoMed's average annual revenue forecast for its fiscal year ending in December 2025 is $4.81M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $7.14M, followed by $7.14M for 2027, and $5.2M for 2028.

What is CervoMed’s net income forecast?

CervoMed's net income forecast for the fiscal year ending in December 2025 stands at $-4.39M, representing a -73.05% decrease from the reported $-16.291M in 2024. Projections indicate $-6.81M in 2026, $-3.894M in 2027, and $-3.62M in 2028.